Cargando…
Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole
The applicant Syngenta Crop Protection AG submitted a request to the competent national authority in Spain to evaluate the confirmatory data that were identified for in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. To addres...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405511/ https://www.ncbi.nlm.nih.gov/pubmed/36034318 http://dx.doi.org/10.2903/j.efsa.2022.7539 |
_version_ | 1784773896596094976 |
---|---|
author | Bellisai, Giulia Bernasconi, Giovanni Brancato, Alba Cabrera, Luis Carrasco Castellan, Irene Ferreira, Lucien Giner, German Greco, Luna Jarrah, Samira Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Robinson, Tobin Ruocco, Silvia Santos, Miguel Scarlato, Alessia Pia Theobald, Anne Verani, Alessia |
author_facet | Bellisai, Giulia Bernasconi, Giovanni Brancato, Alba Cabrera, Luis Carrasco Castellan, Irene Ferreira, Lucien Giner, German Greco, Luna Jarrah, Samira Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Robinson, Tobin Ruocco, Silvia Santos, Miguel Scarlato, Alessia Pia Theobald, Anne Verani, Alessia |
collection | PubMed |
description | The applicant Syngenta Crop Protection AG submitted a request to the competent national authority in Spain to evaluate the confirmatory data that were identified for in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, a new storage stability study, new residues trials and a validated analytical enforcement method for the determination of the relevant residues in animal products were submitted. The data gaps were considered satisfactorily addressed for the plant commodities. The new information provided required a revision of the existing MRL for avocados. As regards the commodities of animal origin, the data gaps were only partially addressed and therefore further risk management considerations are required regarding the revision of the existing MRLs which were derived from Codex MRLs. The risk assessment performed for thiabendazole was also updated. No risk was identified. |
format | Online Article Text |
id | pubmed-9405511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94055112022-08-26 Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole Bellisai, Giulia Bernasconi, Giovanni Brancato, Alba Cabrera, Luis Carrasco Castellan, Irene Ferreira, Lucien Giner, German Greco, Luna Jarrah, Samira Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Robinson, Tobin Ruocco, Silvia Santos, Miguel Scarlato, Alessia Pia Theobald, Anne Verani, Alessia EFSA J Reasoned Opinion The applicant Syngenta Crop Protection AG submitted a request to the competent national authority in Spain to evaluate the confirmatory data that were identified for in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data gaps, a new storage stability study, new residues trials and a validated analytical enforcement method for the determination of the relevant residues in animal products were submitted. The data gaps were considered satisfactorily addressed for the plant commodities. The new information provided required a revision of the existing MRL for avocados. As regards the commodities of animal origin, the data gaps were only partially addressed and therefore further risk management considerations are required regarding the revision of the existing MRLs which were derived from Codex MRLs. The risk assessment performed for thiabendazole was also updated. No risk was identified. John Wiley and Sons Inc. 2022-08-25 /pmc/articles/PMC9405511/ /pubmed/36034318 http://dx.doi.org/10.2903/j.efsa.2022.7539 Text en © 2022 Wiley‐VCH Verlag GmbH & Co. KgaA on behalf of the European Food Safety Authority. https://creativecommons.org/licenses/by-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nd/4.0/ (https://creativecommons.org/licenses/by-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited and no modifications or adaptations are made. |
spellingShingle | Reasoned Opinion Bellisai, Giulia Bernasconi, Giovanni Brancato, Alba Cabrera, Luis Carrasco Castellan, Irene Ferreira, Lucien Giner, German Greco, Luna Jarrah, Samira Leuschner, Renata Magrans, Jose Oriol Miron, Ileana Nave, Stefanie Pedersen, Ragnor Reich, Hermine Robinson, Tobin Ruocco, Silvia Santos, Miguel Scarlato, Alessia Pia Theobald, Anne Verani, Alessia Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole |
title | Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole |
title_full | Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole |
title_fullStr | Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole |
title_full_unstemmed | Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole |
title_short | Evaluation of confirmatory data following the Article 12 MRL review for thiabendazole |
title_sort | evaluation of confirmatory data following the article 12 mrl review for thiabendazole |
topic | Reasoned Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405511/ https://www.ncbi.nlm.nih.gov/pubmed/36034318 http://dx.doi.org/10.2903/j.efsa.2022.7539 |
work_keys_str_mv | AT evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT bellisaigiulia evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT bernasconigiovanni evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT brancatoalba evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT cabreraluiscarrasco evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT castellanirene evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT ferreiralucien evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT ginergerman evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT grecoluna evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT jarrahsamira evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT leuschnerrenata evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT magransjoseoriol evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT mironileana evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT navestefanie evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT pedersenragnor evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT reichhermine evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT robinsontobin evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT ruoccosilvia evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT santosmiguel evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT scarlatoalessiapia evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT theobaldanne evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole AT veranialessia evaluationofconfirmatorydatafollowingthearticle12mrlreviewforthiabendazole |